Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPalace Capital Regulatory News (PCA)

Share Price Information for Palace Capital (PCA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 237.00
Bid: 235.00
Ask: 237.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.851%)
Open: 237.00
High: 0.00
Low: 0.00
Prev. Close: 237.00
PCA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

18 Oct 2022 15:49

RNS Number : 3076D
Palace Capital PLC
18 October 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BF5SGF06

Issuer Name

PALACE CAPITAL PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Harwood Capital LLP

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

4. Details of the shareholder

Name

City of registered office

Country of registered office

HARWOOD CAPITAL LLP

LONDON

UNITED KINGDOM

NORTH ATLANTIC SMALLER COMPANIES INVESTMENT TRUST PLC

London

United Kingdom

5. Date on which the threshold was crossed or reached

14-Oct-2022

6. Date on which Issuer notified

18-Oct-2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

6.320000

0.000000

6.320000

2785000

Position of previous notification (if applicable)

5.170000

0.000000

5.170000

2276973

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BF5SGF06

2740000

6.220000

GB00BF5SGF06

45000

0.100000

Sub Total 8.A

2785000

6.320000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Christopher Harwood Bernard Mills

North Atlantic Smaller Companies Investment Trust Plc

6.220000

6.220000%

Christopher Harwood Bernard Mills

HARWOOD CAPITAL LLP

0.100000

0.100000%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

18-Oct-2022

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEALEPFLPAFFA
Date   Source Headline
14th Jul 20203:05 pmEQSHardman & Co Research: Palace Capital (PCA): Encouraging full-year results
13th Jul 20207:00 amRNSDirector/PDMR Shareholding
9th Jul 20203:28 pmRNSDirector/PDMR Dealing
7th Jul 20202:52 pmRNSFinal Results for the year ended 31 March 2020
7th Jul 20207:00 amRNSFinal Results for the year ended 31 March 2020
3rd Jul 20205:03 pmRNSHolding(s) in Company
3rd Jul 20202:40 pmRNSNotice of Results & Investor Presentation
17th Jun 20205:45 pmEQSCORRECTION: Hardman & Co Research: Palace Capital presenting at virtual Investor Forum on 9th July 2020
17th Jun 20209:27 amEQSHardman & Co Research: Palace Capital presenting at virtual Investor Forum on 9th July 2020
27th Apr 20202:33 pmRNSDirector Dealing
27th Apr 202012:08 pmRNSSecond Price Monitoring Extn
27th Apr 202012:02 pmRNSPrice Monitoring Extension
17th Apr 20207:00 amRNSInvestor presentation
7th Apr 20204:36 pmRNSPrice Monitoring Extension
6th Apr 20203:20 pmEQSHardman & Co Research: Palace Capital (PCA): Trading update and COVID-related dividend cut
2nd Apr 20207:00 amRNSCOVID-19 and dividend update
27th Mar 202010:09 amRNSDirector Dealing
10th Mar 20207:00 amRNSDividend Declaration
10th Feb 20204:40 pmRNSSecond Price Monitoring Extn
10th Feb 20204:35 pmRNSPrice Monitoring Extension
10th Feb 20207:00 amRNSRecord office rent in Hudson Quarter, York
3rd Feb 20207:00 amRNSAppointment of Non-Executive Director
27th Jan 202012:07 pmRNSSecond Price Monitoring Extn
27th Jan 202012:02 pmRNSPrice Monitoring Extension
8th Jan 202011:48 amRNSDirector dealing
12th Dec 201912:07 pmRNSSecond Price Monitoring Extn
12th Dec 201912:02 pmRNSPrice Monitoring Extension
9th Dec 20197:00 amRNSPALACE CAPITAL DISPOSES OF BIRMINGHAM ASSET
27th Nov 20193:35 pmEQSHardman & Co Research: Palace Capital (PCA): 1H'20 results announced
19th Nov 20197:00 amRNSHalf-year Report
24th Oct 20197:00 amRNS17 Lease Renewals and Rent Reviews
23rd Oct 201910:30 amRNSNotice of Interim Results
18th Oct 20193:56 pmRNSDirector dealing
15th Oct 20195:07 pmRNSDirector/PDMR Shareholding
4th Oct 20194:45 pmRNSDirector/PDMR Shareholding
30th Sep 20195:21 pmRNSDirector/PDMR Shareholding
17th Sep 20199:30 amRNSDividend Declaration
7th Aug 20197:00 amRNSIncrease in headroom with £40m refinancing
1st Aug 20197:01 amRNSREIT conversion
1st Aug 20197:00 amRNSNew lease at Sol Northampton
29th Jul 20192:30 pmRNSDirector/PDMR Shareholding
24th Jul 20195:47 pmRNSDirector Dealing
15th Jul 201910:29 amEQSEdison issues outlook on Palace Capital (PCA)
12th Jul 20195:30 pmRNSResult of AGM
12th Jul 20197:00 amRNSAGM Statement
25th Jun 20191:59 pmRNSGrant of awards under LTIP and Deferred Bonus Plan
7th Jun 201912:17 pmEQSHardman & Co Research: Palace Capital (PCA): Conversion to REIT status; FY19 results announced
6th Jun 20196:28 pmRNSDirector/PDMR Shareholding
5th Jun 201911:22 amRNSDirector/PDMR Shareholding
4th Jun 20197:00 amRNSAnnual Results For The Year Ended 31 March 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.